NO20042906L - Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene - Google Patents

Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene

Info

Publication number
NO20042906L
NO20042906L NO20042906A NO20042906A NO20042906L NO 20042906 L NO20042906 L NO 20042906L NO 20042906 A NO20042906 A NO 20042906A NO 20042906 A NO20042906 A NO 20042906A NO 20042906 L NO20042906 L NO 20042906L
Authority
NO
Norway
Prior art keywords
pyrazolybenzylsulfonamides
deuterated
substituted
compounds
drugs containing
Prior art date
Application number
NO20042906A
Other languages
English (en)
Norwegian (no)
Inventor
Rudolf-Giesbert Alken
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of NO20042906L publication Critical patent/NO20042906L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20042906A 2001-12-12 2004-07-09 Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene NO20042906L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10162121A DE10162121A1 (de) 2001-12-12 2001-12-12 Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004600 WO2003050091A1 (de) 2001-12-12 2002-12-11 Deuterierte substituierte pyrazolyl-benzolsulfonamide sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
NO20042906L true NO20042906L (no) 2004-07-09

Family

ID=7709640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042906A NO20042906L (no) 2001-12-12 2004-07-09 Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene

Country Status (14)

Country Link
US (1) US20050222238A1 (pl)
EP (1) EP1456179A1 (pl)
JP (1) JP2005516009A (pl)
CN (1) CN1612863A (pl)
AU (1) AU2002357973A1 (pl)
CA (1) CA2471743A1 (pl)
DE (1) DE10162121A1 (pl)
HU (1) HUP0402422A2 (pl)
IL (1) IL162432A0 (pl)
IS (1) IS7304A (pl)
NO (1) NO20042906L (pl)
PL (1) PL370563A1 (pl)
RU (1) RU2004121033A (pl)
WO (1) WO2003050091A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601737B2 (en) * 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
WO2007012650A1 (en) * 2005-07-26 2007-02-01 Nycomed Gmbh Isotopically substituted proton pump inhibitors
JP5289951B2 (ja) * 2005-07-26 2013-09-11 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング 同位体置換されたパントプラゾール
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
US20070287734A1 (en) * 2006-06-09 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
US20080146573A1 (en) * 2006-12-04 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted oxzolidinones
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
US20090062364A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched celecoxib
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
US20100120756A1 (en) * 2008-09-17 2010-05-13 Auspex Pharmaceuticals, Inc. Phenothiazine modulators of h1 receptors
WO2010056741A2 (en) * 2008-11-12 2010-05-20 Auspex Pharmaceuticals, Inc. Phenylacetic acid inhibitors of cyclooxygenase
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
WO2010138889A1 (en) * 2009-05-28 2010-12-02 Concert Pharmaceuticals, Inc. Peptides for the treatment of hcv infections
MX2012003171A (es) * 2009-09-28 2012-04-11 Hoffmann La Roche Novedosos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
US20150031768A1 (en) * 2011-08-19 2015-01-29 The Trustees Of Princeton University C-halogen bond formation
KR102967223B1 (ko) 2013-12-03 2026-05-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
KR20220054908A (ko) * 2014-04-04 2022-05-03 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
IL281050B2 (en) 2016-03-25 2023-04-01 Intra Cellular Therapies Inc A controlled or delayed release pharmaceutical preparation containing a deuterated compound
JP7013454B2 (ja) 2016-10-12 2022-02-15 イントラ－セルラー・セラピーズ・インコーポレイテッド アモルファス固体分散体
EP3600325A4 (en) 2017-03-24 2021-01-06 Intra-Cellular Therapies, Inc. UNIQUE COMPOSITIONS AND PROCESSES
SMT202600133T1 (it) 2018-03-23 2026-05-12 Intra Cellular Therapies Inc Composti organici
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
WO2020047408A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
AU2019328528B2 (en) 2018-08-31 2025-01-23 Intra-Cellular Therapies, Inc. Novel methods
EP4134101A1 (en) 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder
CN112933085B (zh) * 2020-12-28 2021-12-21 中以海德人工智能药物研发股份有限公司 一种化合物在制备治疗或预防病毒性肝炎用药物中的应用
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2277954A1 (en) * 1993-11-30 1995-06-08 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
DK1104760T3 (da) * 1999-12-03 2003-06-30 Pfizer Prod Inc Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler

Also Published As

Publication number Publication date
IL162432A0 (en) 2005-11-20
WO2003050091A1 (de) 2003-06-19
EP1456179A1 (de) 2004-09-15
IS7304A (is) 2004-06-10
JP2005516009A (ja) 2005-06-02
CA2471743A1 (en) 2003-06-19
CN1612863A (zh) 2005-05-04
RU2004121033A (ru) 2006-01-10
US20050222238A1 (en) 2005-10-06
PL370563A1 (pl) 2005-05-30
HUP0402422A2 (hu) 2005-03-29
AU2002357973A1 (en) 2003-06-23
DE10162121A1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
NO20042907L (no) Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
DK1572707T3 (da) Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
DK1534277T3 (da) Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
DK1401806T3 (da) Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
DK1443917T3 (da) Tamsulosintabletter
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
ATE389392T1 (de) Paracetamol enthaltende tablette
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20035798L (no) Tablett som inneholder cetirizin og pseudoefedrin
NO20042337L (no) Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser
DK1215213T3 (da) Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse
DK1263719T3 (da) N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.
NO20013816L (no) Benzamidderivater og legemidler som inneholder disse
DK1299373T3 (da) Cykliske substituerede aminomethylforbindelser og lægemidler indeholdnede disse forbindelser
FI5009U1 (fi) Tabletti
UA5683S (uk) Пляшка
UA5411S (uk) Пляшка
UA5422S (uk) Флакон
UA5134S (uk) Пляшка
UA5157S (uk) Пляшка
UA5133S (uk) Пляшка
UA5682S (uk) Пляшка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application